NCT06522347招募中不适用
Mycobacteria Registry Study: Prospective Observational Study in Austria
Ludwig Boltzmann Institute for Lung Health3 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2023年1月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 1,000
- 试验地点
- 3
- 主要终点
- Mortality
研究概览
简要总结
The goal of this non-interventional registry study is to systematically collect epidemiological and clinical data throughout the treatment course to learn about effectiveness of treatments. We will document the natural course of therapy without additional interventions. The main question to answer is:
What are the risk factors for mortality due to infection with Mycobacteria tuberculosis (TB) or Nontuberculous mycobacteria (NTM) in Austria?
Data from participants already receiving treatment as part of their regular medical care for TB or NTM infections will be collected.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •patients diagnosed with Mycobacterium tuberculosis or non-tuberculous mycobacteria infection
- •individuals aged 18 years or older
- •written informed consent
排除标准
- •to not comprehend and rightfully judge participation
结局指标
主要结局
Mortality
时间窗: 30 years
Mortality due to tuberculosis or NTM infection in Austria
次要结局
- Patient cohort(30 years)
- Prevalence(30 years)
- Risk factors(30 years)
研究者
Robab Breyer-Kohansal
Prim.a Priv.-Doz.in Dr.in
Ludwig Boltzmann Institute for Lung Health
研究点 (3)
Loading locations...
相似试验
Unknown
不适用
A Prospective Registry For Non Tuberculous Mycobacterial (NTM) InfectionsMycobacterium Infections, NontuberculousNCT02355015Singapore General Hospital200
已完成
不适用
A Study of Treatment Patterns and Outcomes in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Unresectable Locally Advanced or Metastatic Breast CancerLocally Advanced Breast CancerMetastatic Breast CancerNCT02595762Hoffmann-La Roche110
已完成
不适用
Human Epidermal Growth Factor Receptor 2 (HER2) Positive Unresectable Locally Advanced or Metastatic Breast Cancer Disease Registry StudyBreast CancerNCT02393924Hoffmann-La Roche311
已完成
不适用
A Retrospective Epidemiologic Registry to Gain Insight Into the Characteristics and Prognosis of AML Patients According to the Routinely Used Genetic and Biologic MarkersAcute Myeloid LeukemiaNCT05541224PETHEMA Foundation6,917
进行中（未招募）
不适用
The REPLACE Registry for Cholbam® (Cholic Acid)Bile Acid Synthesis DisordersNCT03115086Mirum Pharmaceuticals, Inc.55